Bionomics
- Short interest
- 0.12%
- +0.12 pp 30d
- as of 11 Sept 2023
- Reported shorts
- 1.8M
- Shares on issue
- 1.469B
Bionomics (BNO) Short Interest
Bionomics (ASX:BNO) had 0.12% of shares reported as short positions as of 11 Sept 2023, representing 1,800,000 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Bionomics
Bionomics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel drug candidates for central nervous system (CNS) disorders. Their primary focus is on anxiety, depression, and other neurological conditions, leveraging their proprietary drug discovery platform. The company aims to address significant unmet medical needs through innovative therapeutic approaches, with a lead candidate in late-stage clinical trials.
Company profile →Bionomics (ASX:BNO) has 0.12% of its shares on issue reported as short positions as of 11 Sept 2023, or about 1,800,000 shares. Over the past 30 days that figure has risen 0.12 percentage points, and over 90 days it has risen 0.12 percentage points. Its highest recorded short interest was 0.28% in March 2014. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Company details
website
Be the first to discuss BNO
Start a research thread or post the first pulse update